Leprosy pathogen evades critical vitamin D-dependent immune response

   Jan 30, 12:28 pm

Washington, Jan 30 (ANI): The pathogen behind leprosy has an extraordinary ability to dodge the human immune system by inhibiting the antimicrobial responses vital to our defenses, a new study has revealed.

In one of the first laboratory studies of its kind, researchers discovered that the leprosy pathogen Mycobacterium leprae was able to reduce and evade immune activity that is dependent on vitamin D, a natural hormone that plays an essential role in the body's fight against infections.

The pathogen manipulated micro-RNAs, tiny molecules made of ribonucleic acids that carry information and that help regulate genes to direct cell activity, including immune system defenses.

Micro-RNAs are short RNAs that do not code information for proteins, which carry out all cell activity; rather, they bind to the RNAs that do code for proteins and block them.

The new findings demonstrated how an infectious disease pathogen like M. leprae can use micro-RNAs to impact the immune system's fight response.

"We may find that these tiny micro-RNAs can be exploited by pathogens to weaken our immune response," said the study's first author, Dr. Philip T. Liu, an assistant professor of medicine at the Orthopaedic Hospital Research Center and in the department of dermatology at the David Geffen School of Medicine at UCLA.

"By better understanding how pathogens can escape our immune cells, we can design more effective therapies to boost our immune responses to these difficult to treat infections like leprosy."

Leprosy , one of the world's oldest known diseases, is a chronic infectious disease that affects the skin, the peripheral nerves, the upper respiratory tract and the eyes and can lead to disfigurement of the hands, face and feet.

For the study, researchers compared the micro-RNAs in human skin lesions from two types of leprosy: tuberloid leprosy, a milder infection that is more easily contained, and lepromatous leprosy, which is more serious and causes widespread infection throughout the body.

In the lab, the scientists identified 13 micro-RNAs that differed between the two types of leprosy. The micro-RNAs that were found to be more common in lepromatous leprosy seemed to target the genes important for directing key immune system cells, including macrophages and T cells.

The team found that a particular micro-RNA, hsa-mir-21, inhibited the gene activity of the vitamin D-dependent immune pathway used to help fight infection. When researchers neutralized the activity of hsa-mir-21 in macrophages, the cells were able to kill the bacteria again.

"The leprosy pathogen was able to effectively evade the host's immune response by regulating critical immune system genes," said senior investigator Dr. Robert Modlin, UCLA's Klein Professor of Dermatology and chief of dermatology at the Geffen School of Medicine.

"It's like having the enemy sending a decoy message to your combat troops and telling them to lower their weapons."

To test the significance of this micro-RNA with other infectious diseases, the researchers also introduced hsa-mir-21 to human macrophages that were then infected with tuberculosis in the lab. Researchers found that the micro-RNA similarly blocked the ability of the macrophages to kill the bacteria.

In addition, the team showed that this micro-RNA was found in human immune cells only 18 hours after the onset of leprosy infection. The presence of the micro-RNA so early in the infection suggests it might play a role in actual disease development, the researchers said.

"We may find that a combination of vitamin D supplementation with a genetically targeted therapy could provide an optimal treatment approach to leprosy and possibly other chronic infectious diseases," said Modlin, who also serves as vice chair for cutaneous medicine and dermatological research at UCLA and is a distinguished professor of medicine and of microbiology, immunology and molecular genetics.

The study has been published in the online edition of the journal Nature Medicine. (ANI)

Scientists discover 'chink in HIV's armour' Oct 25, 12:41 pm
Washington, Oct 25 (ANI): Scientists have found a new protein, called Ssu72 that seems to be part of a switch used to awaken HIV-1 (the most common type of HIV) from its slumber.
Full Story
Highest altitude human occupation 1 millennia earlier than previously documented Oct 24, 3:59 pm
Washington, Oct 24 (ANI): An archaeological team has found evidence of the highest altitude human occupied land in the southern Peruvian Andes dated 900 years earlier than previously documented.
Full Story
Scientists shed new light on how hormone works in weight loss Oct 24, 2:30 pm
Washington, Oct 24 (ANI): Scientists have found the how the hormone, which is a popular target to develop weight-loss drugs, works in our body.
Full Story
Hunchback 'Horrible Hands' dino had 'incredibly' long arms Oct 24, 1:57 pm
Washington, Oct 24 (ANI): A new study examined the new fossils of an "incredibly" long-armed dinosaur nicknamed "Horrible Hands" and demonstrated that the dinosaur had a prominent hunchback, was omnivorous, and had features that prevented it from sinking into wet ground.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY